Co-founder and co-CEO, Guardant Health
Appears in 1 story
Leading commercial rollout of Guardant360 Liquid CDx
For most patients with advanced cancer, picking the right targeted drug still starts with a tissue biopsy. On May 20, the FDA approved a blood test that reads 100 times more of the tumor's DNA than the previous version.
Updated May 20
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
